Showing results (51-60 of 161) with videos related to
Sort By:
Pageof 17
Pigment Cell & Melanoma Research|October 1, 2020
Role of serine 365 in BRAF V600E sensitivity to RAF inhibitionMichael J Vido, Justin Rock, Andrew E AplinCancer Discovery|January 16, 2021
Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer ImmunotherapySheera R Rosenbaum, Nicole A Wilski, Andrew E AplinCurrent Opinion in Genetics & Development|January 16, 2002
Anchorage-dependent ERK signaling--mechanisms and consequencesAlan K Howe, Andrew E Aplin, R L JulianoMolecular Cancer Research : MCR|February 13, 2014
Beneficial effects of RAF inhibitor in mutant BRAF splice variant-expressing melanomaEdward J Hartsough, Kevin J Basile, Andrew E AplinThe Journal of Investigative Dermatology|March 10, 2015
NF-κB Regulation of c-FLIP Promotes TNFα-Mediated RAF Inhibitor Resistance in MelanomaYongping Shao, Kaitlyn Le, Hanyin Cheng, et al.Pigment Cell & Melanoma Research|March 16, 2013
Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cellsKaitlyn Le, Erik S Blomain, Ulrich Rodeck, et al.The Journal of Biological Chemistry|August 14, 2015
Fibroblast-derived neuregulin 1 promotes compensatory ErbB3 receptor signaling in mutant BRAF melanomaClaudia Capparelli, Sheera Rosenbaum, Adam C Berger, et al.Cancers|October 14, 2022
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?Imène Krossa, Thomas Strub, Andrew E Aplin, et al.Journal of Cell Science|June 22, 2002
Cell adhesion differentially regulates the nucleocytoplasmic distribution of active MAP kinasesAndrew E Aplin, Brian P Hogan, Jeannie Tomeu, et al.Cancer Cell|February 15, 2014
Wild-type H- and N-Ras promote mutant K-Ras-driven tumorigenesis by modulating the DNA damage responseElda Grabocka, Yuliya Pylayeva-Gupta, Mathew J K Jones, et al.Pageof 17